|
|
| | Orotic acid monohydrate Basic information |
| Product Name: | Orotic acid monohydrate | | Synonyms: | 1,2,3,6-TETRAHYDRO-2,6-DIOXO-4-PYRIMIDINECARBOXYLIC ACID, HYDRATE;2,6-DIOXO-1,2,3,6-TETRAHYDRO-4-PYRIMIDINECARBOXYLIC ACID HYDRATE;2,6-DIOXO-1,2,3,6-TETRAHYDRO-4-PYRIMIDINECARBOXYLIC ACID MONOHYDRATE;2,4-DIHYDROXYPYRIMIDINE-6-CARBOXYLIC ACID HYDRATE;2.4-DIHYDROXYPYRIMIDINE-6-CARBOXYLIC ACID MONOHYDRATE;Orotic acid Monohydrate 97%;Orotic acid Mo;1,2,3,4-Tetrahydro-2,4-dioxo-6-pyrimidine-carboxylicacidmonohydrate | | CAS: | 50887-69-9 | | MF: | C5H6N2O5 | | MW: | 174.11 | | EINECS: | 610-580-2 | | Product Categories: | Building Blocks;C4 to C5;Chemical Synthesis;Heterocyclic Building Blocks;Nutrition Research;Other Biochemical;Phytochemicals by Chemical Classification;Pyrimidines;Miscellaneous Natural Products;Heterocyclic Compounds;Biochemistry;Nucleobases and their analogs;Nucleosides, Nucleotides & Related Reagents;pharmaceutical;bc0001 | | Mol File: | 50887-69-9.mol |  |
| | Orotic acid monohydrate Chemical Properties |
| Melting point | >300 °C(lit.) | | storage temp. | Sealed in dry,Room Temperature | | solubility | Aqueous Base (Slightly), DMSO (Slightly) | | form | Crystalline Powder | | color | White to off-white | | Water Solubility | Soluble in water (1.7 mg/ml), and ammonium hydroxide. Insoluble in chloroform. | | Merck | 14,6876 | | BRN | 383901 | | InChI | InChI=1S/C5H4N2O4.H2O/c8-3-1-2(4(9)10)6-5(11)7-3;/h1H,(H,9,10)(H2,6,7,8,11);1H2 | | InChIKey | YXUZGLGRBBHYFZ-UHFFFAOYSA-N | | SMILES | C1(C(=O)O)NC(NC(=O)C=1)=O.O | | CAS DataBase Reference | 50887-69-9(CAS DataBase Reference) |
| Hazard Codes | Xi | | Risk Statements | 36/37/38 | | Safety Statements | 26-36 | | WGK Germany | 3 | | RTECS | RM3180000 | | TSCA | Yes | | HS Code | 29335990 | | Storage Class | 11 - Combustible Solids | | Hazard Classifications | Eye Irrit. 2
Skin Irrit. 2
STOT SE 3 |
| | Orotic acid monohydrate Usage And Synthesis |
| Chemical Properties | white to off-white crystalline powder | | Uses | Orotic Acid is used in the preparation of therapeutic agents for chronic obstructive pulmonary disease (COPD) treatment. | | Uses | Orotic acid hydrate is used in cosmetic and food industry. It is also used as a pharmaceutical intermediate. | | Purification Methods | It crystallises from water. The anhydrous acid [65-86-1] M 156.1 has m 245-246o(dec). [Nye & Mitchell J Am Chem Soc 69 1382 1947, Beilstein 25 III/IV 1759.] |
| | Orotic acid monohydrate Preparation Products And Raw materials |
|